Drug intelligence / Profile preview

CNC-ala-17-E2

Development stage
Preclinical
Lead developer
German Cancer Research Center
Modality
Small Molecules
Administration
Parenteral
01

Overview

CNC-ala-17-E2 is an experimental hormone-linked nitrosourea designed for the targeted treatment of breast cancer. It consists of a cytotoxic nitrosourea moiety, 1-(2-chloroethyl)-1-nitrosocarbamoyl-L-alanine (CNC-ala), covalently linked to estradiol at the 17-position. This design aims to utilize the estrogen receptor (ER) to selectively deliver the DNA-alkylating nitrosourea to ER-positive tumor cells, thereby increasing local concentration and reducing systemic toxicity. Research has demonstrated its activity in various preclinical models, including MXT mammary carcinoma in mice and MNU-induced mammary carcinoma in rats, although its efficacy in human primary breast carcinoma samples in vitro has shown variability.

Other names
1-(2-chloroethyl)-1-nitrosocarbamoyl-L-alanine-estradiol-17-esterCNC-L-Ala-estradiol-17-esterCNC-L-Ala-estradiol17-esterCNC-L-Ala-estradiol 17-ester

Beyond the preview

Go deeper on CNC-ala-17-E2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CNC-ala-17-E2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call